Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Kuopio – page 14

173 clinical trials in Kuopio, Finland across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Kuopio at a glance
173
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

173 trials in Kuopio

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Mosunetuzumab
  • Sponsor:Oslo University Hospital HF

Dermatitis atopic

Not recruiting
Investigational
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Endometrial cancer

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide
  • Sponsor:Kartos Therapeutics Inc.
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Endometrial cancer

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Status epilepticus

Not recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bexmarilimab
  • Sponsor:Faron Pharmaceuticals Oy

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Kuopio

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Innovative studies focusing on atherosclerotic cardiovascular disease and metabolic conditions. Research includes novel therapies for obesity management and cardiovascular risk reduction.

  • Weight Management Studies
  • Cardiovascular Prevention
  • Type 2 Diabetes Research

Multiple trials evaluating new therapeutic approaches for weight loss and cardiovascular health improvement.

02 Oncology Studies

Comprehensive research in various cancer types, including prostate cancer, breast cancer, and lymphomas. Focus on targeted therapies and treatment optimization.

  • Advanced Breast Cancer Treatments
  • Lymphoma Therapeutics
  • Renal Cell Carcinoma Research

Studies combining immunotherapy approaches with established treatments for better patient outcomes.

03 Inflammatory & Autoimmune Conditions

Research targeting various inflammatory conditions, including psoriatic arthritis and Sjögren's syndrome. Studies evaluating novel biological treatments.

  • Nasal Polyps Treatment
  • Autoimmune Disease Therapies
  • Inflammatory Conditions Management

Innovative approaches in treating chronic inflammatory and autoimmune disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.